Jie Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jie Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Min Wang
The State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases Department of Prosthodontics West China Hospital of Stomatology Sichuan University Sichuan People’s Republic of China
2 shared publications- Yuan Yue
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China
2 shared publications Cheng Su
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
1 shared publicationChuanxi Deng
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
1 shared publication- Hua Tang
Dental Implant Center, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
1 shared publication Jiajia Wang
State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases Department of Prosthodontics West China Hospital of Stomatology Sichuan University Sichuan China
1 shared publication
Latest Publications
- 4 February 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (4) , 1802-1811
Inhibition of Rgs10 aggravates periodontitis with collagen‐induced arthritis via the nuclear factor‐κB pathway
Objective: To explore the role of the Rgs10‐associated nuclear factor (NF)‐κB signalling pathway in periodontitis with rheumatoid arthritis.Methods: Porphyromonas gingivalis and collagen were locally applied to mice to establish in vivo periodontitis and rheumatoid arthritis models, respectively. Both agents were administered together to establish the comorbid group. All models were treated with adeno‐associated virus‐green fluorescent protein (AAV‐GFP) or adeno‐associated virus small hairpin Rgs10 (AAV‐sh‐Rgs10). In vivo expression of Rgs10 and inflammatory cytokines was analysed, along with exploration of the NF‐κB signalling pathway in lipopolysaccharide‐stimulated mouse‐derived RAW264.7 cells, with and without treatment of small interfering RNA (siRNA; Rgs10‐Mus‐MSS245072).Results: In the comorbidity mouse group (mice with both periodontitis and rheumatoid arthritis), inhibition of Rgs10 exacerbated periodontitis, along with upregulation of phospho‐RelA (pP65), tumour necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6) expression in the NF‐κB signalling pathway. Similarly, treatment of LPS‐stimulated RAW264.7 cells with siRNA resulted in the inhibition of Rgs10, along with upregulation of pP65, TNF‐α and IL‐6 expression in vitro.Conclusion: Inhibition of Rgs10 in mice with periodontitis and rheumatoid arthritis can promote the progression of periodontitis, indicating the potential therapeutic role of Rgs10 in this condition.
- 4 February 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (4) , 1802-1811
Inhibition of Rgs10 aggravates periodontitis with collagen‐induced arthritis via the nuclear factor‐κB pathway
Objective: To explore the role of the Rgs10‐associated nuclear factor (NF)‐κB signalling pathway in periodontitis with rheumatoid arthritis.Methods: Porphyromonas gingivalis and collagen were locally applied to mice to establish in vivo periodontitis and rheumatoid arthritis models, respectively. Both agents were administered together to establish the comorbid group. All models were treated with adeno‐associated virus‐green fluorescent protein (AAV‐GFP) or adeno‐associated virus small hairpin Rgs10 (AAV‐sh‐Rgs10). In vivo expression of Rgs10 and inflammatory cytokines was analysed, along with exploration of the NF‐κB signalling pathway in lipopolysaccharide‐stimulated mouse‐derived RAW264.7 cells, with and without treatment of small interfering RNA (siRNA; Rgs10‐Mus‐MSS245072).Results: In the comorbidity mouse group (mice with both periodontitis and rheumatoid arthritis), inhibition of Rgs10 exacerbated periodontitis, along with upregulation of phospho‐RelA (pP65), tumour necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6) expression in the NF‐κB signalling pathway. Similarly, treatment of LPS‐stimulated RAW264.7 cells with siRNA resulted in the inhibition of Rgs10, along with upregulation of pP65, TNF‐α and IL‐6 expression in vitro.Conclusion: Inhibition of Rgs10 in mice with periodontitis and rheumatoid arthritis can promote the progression of periodontitis, indicating the potential therapeutic role of Rgs10 in this condition.
- 25 April 2021
- Published by Wiley in International Endodontic Journal
- Vol. 54 (9) , 1538-1547
Inhibition of receptor‐interacting protein kinase‐3 in the necroptosis pathway attenuates inflammatory bone loss in experimental apical periodontitis in Balb/c mice
Aim: To explore the role of necroptosis in apical periodontitis (AP), this study investigated necroptosis in a Fusobacterium nucleatum (Fn)‐induced AP model of Balb/c mice and explored related intracellular signalling pathways in L929 cells affected by Fn.Methodology: For the in vivo experiments, expression of receptor‐interacting protein kinase‐3 (RIP3) was inhibited using an adeno‐associated virus and then the Balb/c mice model of AP was established by injecting Fn into the root canal of the first mandibular molars. Bone loss and number of osteoclasts were measured via micro‐computed tomography and tartrate‐resistant acid phosphatase staining, respectively; expression of RIP3 and phosphorylated mixed lineage kinase domain‐like protein (pMLKL) was detected by immunohistochemistry and western blotting; expression of mRNA of inflammatory cytokines was evaluated using quantitative real‐time polymerase chain reaction (qRT‐PCR). For the in vitro experiments, L929 cells transfected with RIP3‐Mus‐siRNA or negative control siRNA were co‐cultured with Fn; thereafter, western blotting, detection of cell death and viability and qRT‐PCR analyses were performed to assess the activation of necroptosis pathway and expression of mRNA of inflammatory cytokines. Data were analysed with unpaired t‐test and one‐way analysis of variance with significance set at p < .05.Results: The Fn‐induced apical lesions were associated with apical bone loss, an increased number of osteoclasts, enhanced expression of pMLKL and increased mRNA levels of inflammatory cytokines(IL‐1α and IL‐1β); all these effects were alleviated by RIP3 inhibition (p < .05). L929 cells infected with Fn displayed increased expression of pMLKL and increased cell death (p < .05), together with decreased cell viability (p < .05), whilst transfection with RIP3‐Mus‐siRNA decreased the mRNA expression of inflammatory cytokines(TNF‐α and IL‐6, p < .05).Conclusions: Necroptosis may be involved in AP progression. RIP3 inhibition ameliorated the expression of inflammatory cytokines and bone resorption in Fn‐induced AP lesions in Balb/c mice.
- 25 April 2021
- Published by Wiley in International Endodontic Journal
- Vol. 54 (9) , 1538-1547
Inhibition of receptor‐interacting protein kinase‐3 in the necroptosis pathway attenuates inflammatory bone loss in experimental apical periodontitis in Balb/c mice
Aim: To explore the role of necroptosis in apical periodontitis (AP), this study investigated necroptosis in a Fusobacterium nucleatum (Fn)‐induced AP model of Balb/c mice and explored related intracellular signalling pathways in L929 cells affected by Fn.Methodology: For the in vivo experiments, expression of receptor‐interacting protein kinase‐3 (RIP3) was inhibited using an adeno‐associated virus and then the Balb/c mice model of AP was established by injecting Fn into the root canal of the first mandibular molars. Bone loss and number of osteoclasts were measured via micro‐computed tomography and tartrate‐resistant acid phosphatase staining, respectively; expression of RIP3 and phosphorylated mixed lineage kinase domain‐like protein (pMLKL) was detected by immunohistochemistry and western blotting; expression of mRNA of inflammatory cytokines was evaluated using quantitative real‐time polymerase chain reaction (qRT‐PCR). For the in vitro experiments, L929 cells transfected with RIP3‐Mus‐siRNA or negative control siRNA were co‐cultured with Fn; thereafter, western blotting, detection of cell death and viability and qRT‐PCR analyses were performed to assess the activation of necroptosis pathway and expression of mRNA of inflammatory cytokines. Data were analysed with unpaired t‐test and one‐way analysis of variance with significance set at p < .05.Results: The Fn‐induced apical lesions were associated with apical bone loss, an increased number of osteoclasts, enhanced expression of pMLKL and increased mRNA levels of inflammatory cytokines(IL‐1α and IL‐1β); all these effects were alleviated by RIP3 inhibition (p < .05). L929 cells infected with Fn displayed increased expression of pMLKL and increased cell death (p < .05), together with decreased cell viability (p < .05), whilst transfection with RIP3‐Mus‐siRNA decreased the mRNA expression of inflammatory cytokines(TNF‐α and IL‐6, p < .05).Conclusions: Necroptosis may be involved in AP progression. RIP3 inhibition ameliorated the expression of inflammatory cytokines and bone resorption in Fn‐induced AP lesions in Balb/c mice.
- 11 November 2017
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 47 (2) , 198-205
The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study
Objective: This study was intended to investigate the effects of icariin on the healing of tooth extraction sites under the systemic administration of zoledronic and dexamethasone.Method: Thirty female rats underwent bilateral ovariectomy and were randomly assigned to 5 groups: SS group received a weekly injection of saline, while ZD, ZD + LICA, ZD + MICA, and ZD + HICA groups received zoledronic with dexamethasone for 8 weeks. One week later, mandibular first molars were extracted in all groups. Then, 30, 60, and 120 mg/kg icariin were intragastrically given to ZD + LICA, ZD + MICA, and ZD + HICA groups daily for 10 weeks, while saline was given to SS group and ZD group. Blood samples and mandibles were harvested for examinations after 10 weeks.Results: Significantly smaller wound area was noted in SS and ZD + HICA groups, but the incidence of bisphosphonate‐related osteonecrosis of the jaws (BRONJ) was not significantly different. Groups injected with zoledronic and dexamethasone had higher C‐terminal cross‐linked telopeptide of type 1 collagen (CTX‐1), tartrate‐resistant acid phosphatase 5b (TRACP 5b), and the number of osteoclast cells, with less vascular endothelial growth factor (VEGF) and osteocalcin (OCN). In contrast, CTX‐1, TRACP 5b, and the number of osteoclast cells declined after using icariin and promoted VEGF and OCN were noted and the effects were in a dosage‐dependent manner.Conclusion: Concurrent use of zoledronic and dexamethasone inhibits the expression of VEGF, OCN, and wound healing and increases the number of osteoclast cells, serum CTX‐1, and TRACP‐5b after discontinuation for 10 weeks. Icariin weakens those effects in a dose‐dependent manner but does not influence the onset of BRONJ.
- 11 November 2017
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 47 (2) , 198-205
The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study
Objective: This study was intended to investigate the effects of icariin on the healing of tooth extraction sites under the systemic administration of zoledronic and dexamethasone.Method: Thirty female rats underwent bilateral ovariectomy and were randomly assigned to 5 groups: SS group received a weekly injection of saline, while ZD, ZD + LICA, ZD + MICA, and ZD + HICA groups received zoledronic with dexamethasone for 8 weeks. One week later, mandibular first molars were extracted in all groups. Then, 30, 60, and 120 mg/kg icariin were intragastrically given to ZD + LICA, ZD + MICA, and ZD + HICA groups daily for 10 weeks, while saline was given to SS group and ZD group. Blood samples and mandibles were harvested for examinations after 10 weeks.Results: Significantly smaller wound area was noted in SS and ZD + HICA groups, but the incidence of bisphosphonate‐related osteonecrosis of the jaws (BRONJ) was not significantly different. Groups injected with zoledronic and dexamethasone had higher C‐terminal cross‐linked telopeptide of type 1 collagen (CTX‐1), tartrate‐resistant acid phosphatase 5b (TRACP 5b), and the number of osteoclast cells, with less vascular endothelial growth factor (VEGF) and osteocalcin (OCN). In contrast, CTX‐1, TRACP 5b, and the number of osteoclast cells declined after using icariin and promoted VEGF and OCN were noted and the effects were in a dosage‐dependent manner.Conclusion: Concurrent use of zoledronic and dexamethasone inhibits the expression of VEGF, OCN, and wound healing and increases the number of osteoclast cells, serum CTX‐1, and TRACP‐5b after discontinuation for 10 weeks. Icariin weakens those effects in a dose‐dependent manner but does not influence the onset of BRONJ.